Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priscilla Cascetta

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Lung Cancer (Amsterdam, Netherlands)|June 13, 2022
Targeting BRAF-mutant non-small cell lung cancer: Current status and future directionsMariona Riudavets, Priscilla Cascetta, David Planchard
Journal of Clinical Medicine|March 7, 2020
Combining Immune Checkpoint Inhibitors with Anti-Angiogenic AgentsPaola Ciciola, Priscilla Cascetta, Cataldo Bianco, et al.
International Journal of Molecular Sciences|October 28, 2018
Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and ChemoresistancePriscilla Cascetta, Alessandro Cavaliere, Geny Piro, et al.
Cancers|November 11, 2022
KRAS in NSCLC: State of the Art and Future PerspectivesPriscilla Cascetta, Arianna Marinello, Chiara Lazzari, et al.
Translational Lung Cancer Research|August 13, 2025
<i>KRAS</i> and <i>STK11</i> co-mutations in resectable non-small cell lung cancer: enduring prognostic value and impaired immunotherapy responseLuisana Sisca, Priscilla Cascetta, Ayesha Aijaz, et al.
JTO Clinical and Research Reports|January 8, 2026
Gut Dysbiosis as a Potential Guide for Immunotherapy (Dis)Continuation After 2 Years in NSCLC: A Brief ReportAdele Bonato, Claudia Parisi, Priscilla Cascetta, et al.
Future Oncology (London, England)|May 24, 2022
FOLFIRINOX or nab-paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: an observational studyAlberto Servetto, Antonio Santaniello, Fabiana Napolitano, et al.
Cancers|July 25, 2019
Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature ReviewFabiana Napolitano, Luigi Formisano, Alessandro Giardino, et al.
Frontiers in Oncology|June 14, 2021
Angiogenesis Inhibitors in Small Cell Lung CancerAgnese Montanino, Anna Manzo, Guido Carillio, et al.
Cancers|October 13, 2021
Use of FOLFIRINOX or Nab-Paclitaxel Plus Gemcitabine for the Treatment of Locally Advanced Pancreatic Adenocarcinoma: A Single Institution Observational StudyAlberto Servetto, Antonio Santaniello, Fabiana Napolitano, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Lung Cancer (Amsterdam, Netherlands)|June 13, 2022
Targeting BRAF-mutant non-small cell lung cancer: Current status and future directionsMariona Riudavets, Priscilla Cascetta, David Planchard
Journal of Clinical Medicine|March 7, 2020
Combining Immune Checkpoint Inhibitors with Anti-Angiogenic AgentsPaola Ciciola, Priscilla Cascetta, Cataldo Bianco, et al.
International Journal of Molecular Sciences|October 28, 2018
Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and ChemoresistancePriscilla Cascetta, Alessandro Cavaliere, Geny Piro, et al.
Cancers|November 11, 2022
KRAS in NSCLC: State of the Art and Future PerspectivesPriscilla Cascetta, Arianna Marinello, Chiara Lazzari, et al.
Translational Lung Cancer Research|August 13, 2025
<i>KRAS</i> and <i>STK11</i> co-mutations in resectable non-small cell lung cancer: enduring prognostic value and impaired immunotherapy responseLuisana Sisca, Priscilla Cascetta, Ayesha Aijaz, et al.
JTO Clinical and Research Reports|January 8, 2026
Gut Dysbiosis as a Potential Guide for Immunotherapy (Dis)Continuation After 2 Years in NSCLC: A Brief ReportAdele Bonato, Claudia Parisi, Priscilla Cascetta, et al.
Future Oncology (London, England)|May 24, 2022
FOLFIRINOX or nab-paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: an observational studyAlberto Servetto, Antonio Santaniello, Fabiana Napolitano, et al.
Cancers|July 25, 2019
Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature ReviewFabiana Napolitano, Luigi Formisano, Alessandro Giardino, et al.
Frontiers in Oncology|June 14, 2021
Angiogenesis Inhibitors in Small Cell Lung CancerAgnese Montanino, Anna Manzo, Guido Carillio, et al.
Cancers|October 13, 2021
Use of FOLFIRINOX or Nab-Paclitaxel Plus Gemcitabine for the Treatment of Locally Advanced Pancreatic Adenocarcinoma: A Single Institution Observational StudyAlberto Servetto, Antonio Santaniello, Fabiana Napolitano, et al.
Pageof 2